Idelalisib induced CMV gastrointestinal disease

the need for vigilance with novel therapies

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)555-557
Number of pages3
JournalPathology
Volume49
Issue number5
DOIs
Publication statusPublished - 1 Aug 2017

Cite this

@article{355229d88757464d83c47ae4668fc70a,
title = "Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies",
author = "Lorena Goldring and Beena Kumar and Gan, {T. Eng} and Low, {Michael Sze Yuan}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.pathol.2017.03.009",
language = "English",
volume = "49",
pages = "555--557",
journal = "Pathology",
issn = "0031-3025",
publisher = "Elsevier",
number = "5",

}

Idelalisib induced CMV gastrointestinal disease : the need for vigilance with novel therapies. / Goldring, Lorena; Kumar, Beena; Gan, T. Eng; Low, Michael Sze Yuan.

In: Pathology, Vol. 49, No. 5, 01.08.2017, p. 555-557.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Idelalisib induced CMV gastrointestinal disease

T2 - the need for vigilance with novel therapies

AU - Goldring, Lorena

AU - Kumar, Beena

AU - Gan, T. Eng

AU - Low, Michael Sze Yuan

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85021723662&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2017.03.009

DO - 10.1016/j.pathol.2017.03.009

M3 - Letter

VL - 49

SP - 555

EP - 557

JO - Pathology

JF - Pathology

SN - 0031-3025

IS - 5

ER -